|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 8/99 | |||
| A61K 9/00 | |||
| A61K 47/26 | |||
| A61Q 7/00 | |||
| A61Q 19/08 | |||
| A61P 1/00 | |||
| A61P 5/00 | |||
| A61P 11/00 | |||
| A61P 13/00 | |||
| A61P 17/00 | |||
| A61P 21/00 | |||
| A61P 25/14 | |||
| A61P 27/00 | |||
| A61P 29/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2813239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14180875.8 |
| Date of filing the European patent application | 2005-08-03 | |
| (97) | Date of publication of the European application | 2014-12-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0417367 | 2004-08-04 | GB | |
| 0421290 | 2004-09-24 | GB | |
| 0421288 | 2004-09-24 | GB | |
| 0423952 | 2004-10-28 | GB | |
| 0423953 | 2004-10-28 | GB |
| (72) |
Panjwani, Naveed, GB
Webb, Paul, GB
Pickett, Andrew, GB
|
| (73) |
Ipsen Biopharm Limited,
Ash Road Wrexham Industrial Estate, Clwyd LL13 9UF,
GB
|
| (54) | Pharmaceutical composition containing botulinum neurotoxin A2 |
| Pharmaceutical composition containing botulinum neurotoxin A2 |